Axsome Therapeutics, Inc. , a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States.
Axsome Therapeutics stock last closed at $103.02, up 1.62% from the previous day, and has increased 19.78% in one year. It has overperformed other stocks in the Biotechnology industry by 0.86 percentage points. Axsome Therapeutics stock is currently +42.67% from its 52-week low of $72.21, and -25.95% from its 52-week high of $139.13.
At the moment, there are 49.24M shares of AXSM outstanding. The market cap of AXSM is $5.07B. In the last 24 hours, 839,000 AXSM shares were traded.
How to Buy Axsome Therapeutics Stock
Not sure how to invest in Axsome Therapeutics stock? Here's how.
Choose where to buy Axsome Therapeutics stock: You need to pick an online brokerage, but don't worry - we've analyzed dozens of online brokerages and apps to help you choose where to buy Axsome Therapeutics stock.
Open your brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Put funds into your investment account: Pick your method of payment and add your details.
Evaluate Axsome Therapeutics stock: The Axsome Therapeutics ticker symbol is AXSM. Is Axsome Therapeutics stock a good investment? Should you buy shares of AXSM? How do AXSM's underlying business fundamentals look? Do top analysts think Axsome Therapeutics is a good buy? Why has AXSM's stock price moved recently? (Hint: Our stock analysis website can help you evaluate if AXSM is a good stock to buy).
Make your AXSM purchase: Decide if you will purchase AXSM shares at the current market price or use a limit order to buy AXSM shares at a particular price.
Monitor your AXSM investment: Create a watchlist to keep track of your investment in Axsome Therapeutics stock.
Step 1: Choose where to buy Axsome Therapeutics stock
You will need an online brokerage account to access the NASDAQ market and buy AXSM stock.
A brokerage account is an investment account that enables you to buy and sell a number of investments, including stocks, bonds, mutual funds, and ETFs.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world markets: From Technology to Industrials, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the globe's top exchanges.
Social investing: eToro offers a community with more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of top investors.
Security: eToro is a regulated and licensed fintech leader.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your purchase of stock by signing up for an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Open your brokerage account
Now that you've selected your brokerage, the next step is to fill out some personal information so you can invest in AXSM stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Evaluate Axsome Therapeutics stock
Once you have identified the best place to buy Axsome Therapeutics stock, it's critical to analyze their stock before you buy, so you can understand the risk and upside.
Axsome Therapeutics quick stats
AXSM Price
$103.02
1w %
2.17%
1y %
19.78%
5y %
34.6%
P/E
-17.85x
P/B
95.34x
P/S
11.65x
PEG
N/A
Revenue
$432.16M
Earnings
-$278.27M
Fore. Rev. Growth
47.24%
Fore. Earn. Growth
N/A
Market Cap
$5.07B
Next Earnings
Aug 4, 2025
Next Dividend
N/A
AXSM Due Diligence Checks
WallStreetZen was built to help everyday investors do better fundamental analysis in minutes instead of hours.
There are more short-term assets than short-term liabilities on the AXSM balance sheet.
There are more short-term assets than long-term liabilities on the AXSM balance sheet.
AXSM has cash burn of 118828000. It has enough cash and short-term investments to cover this for at least one year.
AXSM has $300.91M in cash and short term investments. This is sufficient to cover its annual cash burn of $118.83M.
Negative Health Checks:
Total AXSM debt is higher than 5 years ago, relative to shareholder equity.
AXSM has a relatively high debt to equity ratio of 10.22.
AXSM profit margin has gone up by 0.54 percentage points in the past year, but the company is still unprofitable.
Do analysts think it's a good time to buy Axsome Therapeutics stock
Out of 16 Wall Street analysts who give forecasts on AXSM, the consensus analyst rating on Axsome Therapeutics is a Strong Buy
It's important to keep in mind that analyst ratings are not stock recommendations, nor are they investment advice.
Most Recent AXSM Analyst Upgrades/Downgrades
Cerena Chen, a bottom 29% analyst from Wells Fargo maintains AXSM with a strong buy rating and raises their AXSM price target from $160.00 to $165.00, on May 6, 2025.
Joel Beatty, a top 19% analyst from Baird maintains AXSM with a buy rating and raises their AXSM price target from $160.00 to $162.00, on May 6, 2025.
Andrew Tsai, a bottom 6% analyst from Jefferies initiates coverage on AXSM with a strong buy rating and announces their AXSM price target of $200.00, on Apr 7, 2025.
Graig Suvannavejh, a top 37% analyst from Mizuho maintains AXSM with a buy rating and raises their AXSM price target from $212.00 to $216.00, on Mar 27, 2025.
Vikram Purohit, a bottom 6% analyst from Morgan Stanley maintains AXSM with a strong buy rating and raises their AXSM price target from $125.00 to $190.00, on Feb 27, 2025.
Last year, AXSM revenue was $432.16M. During the last two year, AXSM's revenue has increased by 72.87% per year. This was faster than the Biotechnology industry average of 45.26%.
No, Axsome Therapeutics doesn't provide an income stream by paying out dividends.
AXSM Social Trading Data
One of the major reasons eToro is our highest-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your AXSM purchase
There are two main types of orders:
Market order: A market order is an order to buy or sell a stock at the best possible price. Market orders are usually the best for newer investors.
Limit order: A limit order is an order to buy or sell a stock at a specific price (or better). If you want to make sure you're buying or selling at a given dollar amount, use a limit order.
Hit the Open Trade button and your broker will execute your order.
If you require more info about investing in stocks on eToro, click the how to video below:
How much does it cost to buy one Axsome Therapeutics share?
As of Aug 1, 2025, it costs $103.02 to buy one share of Axsome Therapeutics stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $10, you can buy 0.097 shares of AXSM.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.